MEETINGS - Symposium on Pharmacogenics, SNPs & Genetic Patenting (US) May - June 2000:
This article was originally published in Clinica
IBC US conferences will hold its annual symposium on Pharmacogenics, SNPs & Genetic Patenting in Newark, New Jersey on May 31-June 2. Topics for discussion include: typing genomics to medicine: clinical resources for the post-genomics era; role of genetic epidemiology in pharmacogenics; impact of pharmacogenetics on treatment of diabetes, alzheimer's and cardiovascular disease; and delivery pharmacogenomics over the internet. For more information contact IBC in the US. Tel: +1 508 481 6400. Fax: +1 508 481 7911.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.